Getting academic diagnostic discoveries to market: 6 tips from industry
“Wouldn’t it be great if we could come up with a noninvasive diagnostic assay to detect pancreatic cancer at an earlier, more treatable stage?” asked Lori Aro of Myriad Genetics. Her company has been trying to do so for years. So why hasn’t it happened? Aro, senior director for new product planning at Myriad, outlined...
The post Getting academic diagnostic discoveries to market: 6 tips from industry appeared first on Vector.
The genetics of early-onset psychosis: Could it aid understanding of schizophrenia?
At age six, Matthew (not his real name) began hearing voices coming out of the walls and the school intercom, telling him to hurt himself and others. He saw ghosts, aliens in trees and color footprints. Joseph Gonzalez-Heydrich, MD, a psychiatrist at Boston Children’s Hospital, put Matthew, at age 9, on antipsychotic medications, and the...
The post The genetics of early-onset psychosis: Could it aid understanding of schizophrenia? appeared first on Vector.
Who We are
The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.
News and Events
FY 2015 TIDO Annual Report Released
Fiscal Year 2015 was a year of growth at TIDO. Boston Children’s executed 48 licenses, a 42 percent increase over the prior year, while the total number of executed industry research and license agreements reached 91, an increase of 17 percent over the prior year. The report highlights selected agreements, Technology Development Fund award winners, and some of our technologies available for licensing.
Updated Material Transfer Agreement (MTA) Procedures (Click here)
The new IP Policy allows for researchers to independently generate and complete certain outbound academic MTAs if specific criteria are met. In addition, we have implemented a new form for initiating inbound MTAs. Please click the link above for instructions and to download the forms.